Home / Pharmaceuticals / Insomnia Treatment Drugs Market By Treatment Type (Prescription Sleep Aids, Over The Counter (OTC) Sleep Aids) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Insomnia Treatment Drugs Market By Treatment Type (Prescription Sleep Aids, Over The Counter (OTC) Sleep Aids) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

Published: Aug 2018 | Report Code: 59249-08-18

Industry Outlook

The insomnia treatment drugs market is set to reach US$ 4,332.4 Mn by 2026 from US$ 2,689.6 Mn in 2017 highlighting balanced growth at a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2018 to 2026. As per the research citing of United Nations (UN) by 2030 the geriatric population suffering with insomnia is going to rise by 56%. Insomnia is caused by factors such as stress, addiction, irregular circadian rhythm, chronic pain etc. The major concern of insomnia is it remains undiagnosed, and lack of early medical intervention results in serious health concern. Pharmaceutical companies are investing in the formulation research and development segment to reduce the adverse effects associated with the medicines prescribed for insomnia treatment.

Melatonin is recommended in patients suffering with circadian rhythm disorder and lack of sleep due to jet lag. In developing countries such as China and India the dietary supplements such as valerian roots, chamomile, passionflower tea etc., are finding prominence in treating insomnia effectively. Domicile of key players pioneering in the treatment of insomnia and growing health awareness makes North America the global leader in the insomnia treatment drugs market. Increasing geriatric population, effective insomnia diagnosis and developing healthcare infrastructure propels the market growth in Asia Pacific region.

Market Synopsis

Insomnia Treatment Drugs Market

Increasing health awareness regarding insomnia treatment to propel the prescription sleep aids market

As if now the prescription sleep aids are commanding the insomnia treatment drugs market. Physicians throughout the globe are prescribing benzodiazepines, antidepressant and orexin antagonist to patients suffering with sleep disorder. Benzodiazepine such as alprazolam, diazepam, and clonazepam are prescribed in patients suffering with insomnia due to anxiety. Antidepressant are given in combination with zolpidem (sedative) in patients suffering with insomnia due to neuropsychiatric ailment.  The challenges faced by the prescription sleep aid drugs are the severe adverse effects associated with it such as withdrawal symptoms, psychosis and seizures. Over the counter sleep aids will be projecting excellent market growth during the forecast period owing to rising popularity in developing countries, low cost and no adverse effects.

Insomnia Treatment Drugs Market

Increasing geriatric population suffering with insomnia to drive the insomnia treatment drugs market in Asia Pacific region

Currently North America is dominating the regional segment for insomnia treatment drugs market and accounts for approximately 55% of the total market share. The key drivers responsible for the dominance of North America are presence of pharmaceutical companies such as Sanofi S.A., and F.Hoffman La-Roche AG etc., catering the medication supply for insomnia treatment. Existence of well-developed healthcare infrastructure and affordable reimbursement scenario for insomnia treatment drugs propel the market growth in North America. Asia Pacific is anticipated to showcase remarkable growth during the forecast period 2018 to 2026. Increasing geriatric population suffering with sleep disorder and rising mental health awareness is having a positive impact on the insomnia treatment drugs market in Asia Pacific region. Supportive regulatory environment and increasing funding in the healthcare segment by government and pharmaceutical companies to support the market growth in Latin America and Middle East and Africa.

Insomnia Treatment Drugs Market

Historical & Forecast Period

2016 – Historical Year

2017 – Base Year

2018-2026 – Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Insomnia Treatment Drugs Market

Report Scope by Segments

On the basis of the current market trends the quantitative analysis for the report insomnia treatment drugs market is postulated. The market segmentation comprises of treatment type and geography.

By Treatment Type (2016–2026; US$ Mn)

  • Prescription Sleep Aids
    • Benzodiazepine
    • Antidepressant
    • Orexin Antagonist
  • Over the Counter (OTC) Sleep Aids
    • Antihistamine
    • Melatonin
    • Dietary Supplement

Geography Segment (2016–2026; US$ Mn)

  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • Rest of APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • GCC
    • Rest of Middle East and Africa

Market assessment is performed to understand the latest market trend in order to cater the quantitative analysis for insomnia treatment drugs market. Merger and acquisition and strategic decision between the pharmaceutical industry and research academia is highlighted in the report to understand the medicinal requirement of the patients suffering with insomnia. Product portfolio provides valuable insights regarding the different brands of medication available for the treatment of insomnia. The major players actively engaged in the manufacturing of insomnia treatment drugs are F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd, Teva Pharmaceutical Industries Ltd. and Vanda Pharmaceuticals, Inc.

Key questions answered in this report

  • What will be the performance of the market during the forecast period from 2018 to 2026?
  • Who are the leading players in the insomnia treatment drugs market?
  • What are the current market dynamics prevalent in the insomnia treatment drugs market?
  • What are the opportunities and restraints that control the insomnia treatment drugs market?
  • What are the medications available and the treatment regimen adopted throughout the globe?
  • Which is the leading and fastest growing region in the global insomnia treatment drugs market?
  • What is the disease etiology of insomnia and how it would impact the market growth?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Insomnia Treatment Drugs Market Portraiture
2.2. Global Insomnia Treatment Drugs Market, by Treatment Type, 2017 (US$ Mn)
2.3. Global Insomnia Treatment Drugs Market, by Geography, 2017 (US$ Mn)

Chapter 3. Insomnia Treatment Drugs Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Insomnia Treatment Drugs Market, by Key Players, 2017

Chapter 4. Global Insomnia Treatment Drugs Market, by Treatment Type
4.1. Overview
4.2. Prescription Sleep Aids
4.2.1. Benzodiazepine
4.2.2. Antidepressant
4.2.3. Orexin Antagonist
4.3. Over the Counter (OTC) Sleep Aids
4.3.1. Antihistamines
4.3.2. Melatonin
4.3.3. Dietary Supplement

Chapter 5. Global Insomnia Treatment Drugs Market, by Geography
5.1. Overview
5.2. North America Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.2.1. North America Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.2.2. North America Insomnia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.3.1. Europe Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.4.1. Asia Pacific Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.5.1. Latin America Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.6.1. MEA Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.6.2. MEA Insomnia Treatment Drugs Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. F.Hoffman La-Roche AG
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. Merck & Co. Inc.
6.3. Mylan N.V.
6.4. Pernix Therapeutics
6.5. Pfizer, Inc.
6.6. Sanofi S.A.
6.7. Sumitomo Dainippon Pharma Co., Ltd
6.8. Takeda Pharmaceutical Company Ltd.
6.9. Teva Pharmaceutical Industries Ltd.
6.10. Vanda Pharmaceuticals, Inc.

FIG. 1 Insomnia Treatment Drugs Market: Research Methodology
FIG. 2 Insomnia Treatment Drugs: Market Segmentation
FIG. 3 Global Insomnia Treatment Drugs Market, by Treatment Type, 2017 (US$ Mn)
FIG. 4 Global Insomnia Treatment Drugs Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2017
FIG. 6 Competitive Analysis: Global Insomnia Treatment Drugs Market, by Key Players, 2017
FIG. 7 Global Benzodiazepine Drugs Market for Insomnia Treatment, 2016 – 2026 (US$ Mn)
FIG. 8 Global Antidepressant Drugs Market for Insomnia Treatment, 2016 – 2026 (US$ Mn)
FIG. 9 Global Orexin Antagonist Drugs Market for Insomnia Treatment, 2016 – 2026 (US$ Mn)
FIG. 10 Global Antihistamine Drugs Market for Insomnia Treatment, 2016 – 2026 (US$ Mn)
FIG. 11 Global Melatonin Market for Insomnia Treatment, 2016 – 2026 (US$ Mn)
FIG. 12 Global Dietary Supplements Market for Insomnia Treatment, 2016 – 2026 (US$ Mn)
FIG. 13 U.S. Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 14 Canada Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 15 U.K. Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 16 Germany Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 17 Rest of Europe Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 18 China Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 19 Japan Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 20 Rest of Asia Pacific Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 21 Brazil Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 22 Mexico Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 23 Rest of Latin America Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 24 GCC Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Middle East and Africa Insomnia Treatment Drugs Market, 2016 – 2026 (US$ Mn)

TABLE 1 Global Insomnia Treatment Drugs Market Portraiture
TABLE 2 Global Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Prescription Sleep Aids Market for Insomnia Treatment, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global OTC Sleep Aids Market for Insomnia Treatment, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global Insomnia Treatment Drugs Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America Insomnia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Insomnia Treatment Drugs Market, by Country/Region, 2015 – 2025 (US$ Mn)
TABLE 12 Latin America Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Middle East and Africa Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
TABLE 15 Middle East and Africa Insomnia Treatment Drugs Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 16 F.Hoffman La-Roche AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 Merck & Co. Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 Mylan N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Pernix Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Sumitomo Dainippon Pharma Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Takeda Pharmaceuticals Company Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Vanda Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients